companies / proximabio-com
Generated UTC · publication cutoff 2026-11-09
Insufficient cited evidence for a two-sentence summary.
verified=2026-05-13 json
| total_raised | 86,300,00086.3M | ○ |
|---|---|---|
| founded | 2019 | |
| hq | New York | |
| industry | unknown | |
| stage | seed |
Proxima is a biotech company with an AI-powered drug discovery platform focused on making protein interactions programmable through proximity modulators. It serves pharma and biotech partners, including Bristol Myers Squibb. Its differentiator is an integrated platform of three technologies built for the proximity modulator modality.
No cited completed company acquisition recorded.
Dated disclosures. Customer relationships and classifications are historical; ARR is separate from revenue.
No cited disclosure recorded: named customer, disclosed revenue, ARR, count, B2B / B2C, sector, go-to-market.
No cited valuation with an explicit basis is recorded.
Historical post-money / actual annual or stated TTM revenue. Same currency; economic valuation date within 90 days of revenue period end, inclusive. No FX, ARR, annualized revenue, estimates or projections. Conflicts and ambiguous ties are withheld.
No qualifying pair recorded.
| date | type | amount | lead | src |
|---|---|---|---|---|
| 2026-01-01 | seed | 86,300,00086.3M | null | ○ |
Vercel, Underscore.js, Next.js, React
| fact | status | src |
|---|---|---|
| Seed, $86.3M | attributed | ○ |
| existence | self-reported | WEB |
| description | self-reported | WEB |